These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12218408)

  • 1. Excess DNA mutations seen in babies whose HIV-infected mothers took antiretroviral drugs.
    Susman E
    AIDS; 2002 Sep; 16(13):N9-10. PubMed ID: 12218408
    [No Abstract]   [Full Text] [Related]  

  • 2. Is peripartum zidovudine 'safe and highly beneficial to African children?'.
    Crowe DR
    AIDS; 2001 Nov; 15(16):2204-5. PubMed ID: 11684947
    [No Abstract]   [Full Text] [Related]  

  • 3. Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission.
    Giaquinto C; De Romeo A; Giacomet V; Rampon O; Ruga E; Burlina A; De Rossi A; Sturkenboom M; D'Elia R
    AIDS; 2001 May; 15(8):1074-5. PubMed ID: 11399997
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.
    Mofenson LM; Munderi P
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):200-15. PubMed ID: 12045684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine-induced resistance is a problem.
    S Afr Med J; 2004 May; 94(5):338. PubMed ID: 15211947
    [No Abstract]   [Full Text] [Related]  

  • 6. Protease inhibitor treatment in HIV pregnant women. Is it safe for newborns?
    García-Tejedor A; Perales A; Maiques V
    Int J Gynaecol Obstet; 2002 Feb; 76(2):175-6. PubMed ID: 11818114
    [No Abstract]   [Full Text] [Related]  

  • 7. US Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States, February 25, 2000.
    United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group
    HIV Clin Trials; 2000; 1(2):39-64. PubMed ID: 11590498
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy.
    Grubert TA; Wintergerst U; Lutz-Friedrich R; Belohradsky BH; Rolinski B
    AIDS; 1999 Jul; 13(11):1430-1. PubMed ID: 10449309
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatments to reduce mother-to-child transmission of HIV.
    Peiperl L
    HIV Clin Trials; 2001; 2(1):46-55. PubMed ID: 11590514
    [No Abstract]   [Full Text] [Related]  

  • 12. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).
    United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group Members
    HIV Clin Trials; 2001; 2(1):56-91. PubMed ID: 11590515
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating HIV during pregnancy: an update on safety issues.
    Watts DH
    Drug Saf; 2006; 29(6):467-90. PubMed ID: 16752931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of mother-infant HIV transmission. Thailand, 1998-2000. Part I.
    Wkly Epidemiol Rec; 2001 Aug; 76(33):253-5. PubMed ID: 11530679
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral drugs to prevent breastfeeding HIV transmission.
    Mofenson LM
    Antivir Ther; 2010; 15(4):537-53. PubMed ID: 20587847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IAS position paper on prevention of HIV 1 mother-to-child transmission. International Aids Society.
    AIDS; 1999 Jul; 13(11):5-9. PubMed ID: 10449274
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.
    Lorenzi P; Spicher VM; Laubereau B; Hirschel B; Kind C; Rudin C; Irion O; Kaiser L
    AIDS; 1998 Dec; 12(18):F241-7. PubMed ID: 9875571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
    Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
    J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.